Search research articles
Contact Us
Filters
Showing results (21-30 of 73) with videos related to
Page
of 8
Sort By:
Blood
|
December 4, 2024
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myeloma
Dan T Vogl, Shebli Atrash, Sarah A Holstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2017
Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dan T Vogl, Noopur Raje, Sundar Jagannath, et al.
Leukemia
|
February 15, 2019
RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation
Nan Zhou, Alvaro Gutierrez-Uzquiza, Xiang Yu Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2025
A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death-Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma
Taxiarchis Kourelis, Sikander Ailawadhi, Dan T Vogl, et al.
Kidney International
|
May 16, 2018
A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
Ramnika Gumber, Jordana B Cohen, Matthew B Palmer, et al.
Cancer Research Communications
|
March 16, 2023
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
Cindy Lin, Laura Garcia-Gerique, Erin E Bonner, et al.
Blood
|
September 19, 2015
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Jatin J Shah, Edward A Stadtmauer, Rafat Abonour, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice
Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma
Thomas M Paul, Stephen V Liu, Elise A Chong, et al.
JCI Insight
|
May 7, 2024
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice
Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 73) with videos related to
Sort By:
Page
of 8
Blood
|
December 4, 2024
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myeloma
Dan T Vogl, Shebli Atrash, Sarah A Holstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2017
Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dan T Vogl, Noopur Raje, Sundar Jagannath, et al.
Leukemia
|
February 15, 2019
RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation
Nan Zhou, Alvaro Gutierrez-Uzquiza, Xiang Yu Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2025
A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death-Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma
Taxiarchis Kourelis, Sikander Ailawadhi, Dan T Vogl, et al.
Kidney International
|
May 16, 2018
A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
Ramnika Gumber, Jordana B Cohen, Matthew B Palmer, et al.
Cancer Research Communications
|
March 16, 2023
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
Cindy Lin, Laura Garcia-Gerique, Erin E Bonner, et al.
Blood
|
September 19, 2015
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Jatin J Shah, Edward A Stadtmauer, Rafat Abonour, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice
Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma
Thomas M Paul, Stephen V Liu, Elise A Chong, et al.
JCI Insight
|
May 7, 2024
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice
Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Page
of 8